Definition, diagnosis, and management of intravascular large B-cell lymphoma

Proposals and perspectives from an international consensus meeting

Maurilio Ponzoni, Andrés J M Ferreri, Elías Campo, Fabio Facchetti, Luca Mazzucchelli, Tadashi Yoshino, Takuhei Murase, Stefano A. Pileri, Claudio Doglioni, Emanuele Zucca, Franco Cavalli, Shigeo Nakamura

Research output: Contribution to journalArticle

266 Citations (Scopus)

Abstract

Intravascular large B-cell lymphoma (IVLBCL) is a rare form of diffuse LBCL characterized by preferential intravascular growth of malignant lymphocytes, aggressive behavior, and an often fatal course. IVLBCL usually affects elderly patients with poor performance status, elevated lactic dehydrogenase serum levels, anemia, and B symptoms. It displays some differences in clinical presentation among diverse geographical areas, mostly between patients diagnosed in Western countries and Japan. In addition, data from the literature suggest that pathologic diagnostic criteria as well as clinical features of this disease may be broader than described in current classification scheme(s). Under the sponsorship of the International Extranodal Lymphoma Study Group, clinicians and pathologists with interest in IVLBCL, coming from Western and Eastern countries, joined to reach a consensus on defining features as well as to focus on the most urgent unresolved issues in IVLBCL. To this end, a representative group of IVLBCL patients coming from both the aforementioned geographical areas were collectively analyzed. Additional features of IVLBCL were proposed both under clinical and pathologic stand points. At the meeting, it emerged that IVLBCL may have additional histopathologic/cytologic definition criteria with respect to those currently recommended, some clinical features are not randomly distributed worldwide, recent therapeutic approaches, such as anti-CD20-containing regimens, may improve outcome, and kidney, spleen, and liver involvement may show peculiar histopathologic features. Finally, a provisional practical diagnostic approach to hemophagocytosis-associated patients and a proposal for the most useful criteria in the settings of differential diagnosis are included.

Original languageEnglish
Pages (from-to)3168-3173
Number of pages6
JournalJournal of Clinical Oncology
Volume25
Issue number21
DOIs
Publication statusPublished - Jul 20 2007
Externally publishedYes

Fingerprint

Internationality
B-Cell Lymphoma
Anemia
Lymphoma
Japan
Oxidoreductases
Milk
Differential Diagnosis
Spleen
Lymphocytes
Kidney
Liver
Growth
Serum

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Definition, diagnosis, and management of intravascular large B-cell lymphoma : Proposals and perspectives from an international consensus meeting. / Ponzoni, Maurilio; Ferreri, Andrés J M; Campo, Elías; Facchetti, Fabio; Mazzucchelli, Luca; Yoshino, Tadashi; Murase, Takuhei; Pileri, Stefano A.; Doglioni, Claudio; Zucca, Emanuele; Cavalli, Franco; Nakamura, Shigeo.

In: Journal of Clinical Oncology, Vol. 25, No. 21, 20.07.2007, p. 3168-3173.

Research output: Contribution to journalArticle

Ponzoni, M, Ferreri, AJM, Campo, E, Facchetti, F, Mazzucchelli, L, Yoshino, T, Murase, T, Pileri, SA, Doglioni, C, Zucca, E, Cavalli, F & Nakamura, S 2007, 'Definition, diagnosis, and management of intravascular large B-cell lymphoma: Proposals and perspectives from an international consensus meeting', Journal of Clinical Oncology, vol. 25, no. 21, pp. 3168-3173. https://doi.org/10.1200/JCO.2006.08.2313
Ponzoni, Maurilio ; Ferreri, Andrés J M ; Campo, Elías ; Facchetti, Fabio ; Mazzucchelli, Luca ; Yoshino, Tadashi ; Murase, Takuhei ; Pileri, Stefano A. ; Doglioni, Claudio ; Zucca, Emanuele ; Cavalli, Franco ; Nakamura, Shigeo. / Definition, diagnosis, and management of intravascular large B-cell lymphoma : Proposals and perspectives from an international consensus meeting. In: Journal of Clinical Oncology. 2007 ; Vol. 25, No. 21. pp. 3168-3173.
@article{db4046a717424782998dbc303c18524f,
title = "Definition, diagnosis, and management of intravascular large B-cell lymphoma: Proposals and perspectives from an international consensus meeting",
abstract = "Intravascular large B-cell lymphoma (IVLBCL) is a rare form of diffuse LBCL characterized by preferential intravascular growth of malignant lymphocytes, aggressive behavior, and an often fatal course. IVLBCL usually affects elderly patients with poor performance status, elevated lactic dehydrogenase serum levels, anemia, and B symptoms. It displays some differences in clinical presentation among diverse geographical areas, mostly between patients diagnosed in Western countries and Japan. In addition, data from the literature suggest that pathologic diagnostic criteria as well as clinical features of this disease may be broader than described in current classification scheme(s). Under the sponsorship of the International Extranodal Lymphoma Study Group, clinicians and pathologists with interest in IVLBCL, coming from Western and Eastern countries, joined to reach a consensus on defining features as well as to focus on the most urgent unresolved issues in IVLBCL. To this end, a representative group of IVLBCL patients coming from both the aforementioned geographical areas were collectively analyzed. Additional features of IVLBCL were proposed both under clinical and pathologic stand points. At the meeting, it emerged that IVLBCL may have additional histopathologic/cytologic definition criteria with respect to those currently recommended, some clinical features are not randomly distributed worldwide, recent therapeutic approaches, such as anti-CD20-containing regimens, may improve outcome, and kidney, spleen, and liver involvement may show peculiar histopathologic features. Finally, a provisional practical diagnostic approach to hemophagocytosis-associated patients and a proposal for the most useful criteria in the settings of differential diagnosis are included.",
author = "Maurilio Ponzoni and Ferreri, {Andr{\'e}s J M} and El{\'i}as Campo and Fabio Facchetti and Luca Mazzucchelli and Tadashi Yoshino and Takuhei Murase and Pileri, {Stefano A.} and Claudio Doglioni and Emanuele Zucca and Franco Cavalli and Shigeo Nakamura",
year = "2007",
month = "7",
day = "20",
doi = "10.1200/JCO.2006.08.2313",
language = "English",
volume = "25",
pages = "3168--3173",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "21",

}

TY - JOUR

T1 - Definition, diagnosis, and management of intravascular large B-cell lymphoma

T2 - Proposals and perspectives from an international consensus meeting

AU - Ponzoni, Maurilio

AU - Ferreri, Andrés J M

AU - Campo, Elías

AU - Facchetti, Fabio

AU - Mazzucchelli, Luca

AU - Yoshino, Tadashi

AU - Murase, Takuhei

AU - Pileri, Stefano A.

AU - Doglioni, Claudio

AU - Zucca, Emanuele

AU - Cavalli, Franco

AU - Nakamura, Shigeo

PY - 2007/7/20

Y1 - 2007/7/20

N2 - Intravascular large B-cell lymphoma (IVLBCL) is a rare form of diffuse LBCL characterized by preferential intravascular growth of malignant lymphocytes, aggressive behavior, and an often fatal course. IVLBCL usually affects elderly patients with poor performance status, elevated lactic dehydrogenase serum levels, anemia, and B symptoms. It displays some differences in clinical presentation among diverse geographical areas, mostly between patients diagnosed in Western countries and Japan. In addition, data from the literature suggest that pathologic diagnostic criteria as well as clinical features of this disease may be broader than described in current classification scheme(s). Under the sponsorship of the International Extranodal Lymphoma Study Group, clinicians and pathologists with interest in IVLBCL, coming from Western and Eastern countries, joined to reach a consensus on defining features as well as to focus on the most urgent unresolved issues in IVLBCL. To this end, a representative group of IVLBCL patients coming from both the aforementioned geographical areas were collectively analyzed. Additional features of IVLBCL were proposed both under clinical and pathologic stand points. At the meeting, it emerged that IVLBCL may have additional histopathologic/cytologic definition criteria with respect to those currently recommended, some clinical features are not randomly distributed worldwide, recent therapeutic approaches, such as anti-CD20-containing regimens, may improve outcome, and kidney, spleen, and liver involvement may show peculiar histopathologic features. Finally, a provisional practical diagnostic approach to hemophagocytosis-associated patients and a proposal for the most useful criteria in the settings of differential diagnosis are included.

AB - Intravascular large B-cell lymphoma (IVLBCL) is a rare form of diffuse LBCL characterized by preferential intravascular growth of malignant lymphocytes, aggressive behavior, and an often fatal course. IVLBCL usually affects elderly patients with poor performance status, elevated lactic dehydrogenase serum levels, anemia, and B symptoms. It displays some differences in clinical presentation among diverse geographical areas, mostly between patients diagnosed in Western countries and Japan. In addition, data from the literature suggest that pathologic diagnostic criteria as well as clinical features of this disease may be broader than described in current classification scheme(s). Under the sponsorship of the International Extranodal Lymphoma Study Group, clinicians and pathologists with interest in IVLBCL, coming from Western and Eastern countries, joined to reach a consensus on defining features as well as to focus on the most urgent unresolved issues in IVLBCL. To this end, a representative group of IVLBCL patients coming from both the aforementioned geographical areas were collectively analyzed. Additional features of IVLBCL were proposed both under clinical and pathologic stand points. At the meeting, it emerged that IVLBCL may have additional histopathologic/cytologic definition criteria with respect to those currently recommended, some clinical features are not randomly distributed worldwide, recent therapeutic approaches, such as anti-CD20-containing regimens, may improve outcome, and kidney, spleen, and liver involvement may show peculiar histopathologic features. Finally, a provisional practical diagnostic approach to hemophagocytosis-associated patients and a proposal for the most useful criteria in the settings of differential diagnosis are included.

UR - http://www.scopus.com/inward/record.url?scp=34547661620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547661620&partnerID=8YFLogxK

U2 - 10.1200/JCO.2006.08.2313

DO - 10.1200/JCO.2006.08.2313

M3 - Article

VL - 25

SP - 3168

EP - 3173

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 21

ER -